Alpha Cognition Inc. (ACOG) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $62.00; Common Stock, Value, IssuedUSD $133.95M; Additional Paid in CapitalUSD $31.49M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.30K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $62.00; Common Stock, Value, IssuedUSD $133.95M; Additional Paid in CapitalUSD $27.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.30K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $62.00; Common Stock, Value, IssuedUSD $133.89M; Additional Paid in CapitalUSD $25.85M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.30K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $62.00; Common Stock, Value, IssuedUSD $101.83M; Additional Paid in CapitalUSD $22.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.30K.
Alpha Cognition Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $62.00 | $133.95M | $31.49M | $-104.30K | $-112.37M | $52.96M | (m) | 3 month · $1.45M 6 month · $2.86M | (m) | (m) |
| 2026-03-31 | $62.00 | $133.95M | $27.19M | $-104.30K | $-103.58M | $57.46M | (m) | 3 month · $1.40M | (m) | (m) |
| 2025-12-31 | $62.00 | $133.89M | $25.85M | $-104.30K | $-97.11M | $62.53M | (m) | 12 month · $3.77M | (m) | 12 month · $5.57M |
| 2025-09-30 | $62.00 | $101.83M | $22.29M | $-104.30K | $-90.10M | $33.91M | (m) | 3 month · $1.07M 9 month · $3.98M | (m) | (m) |
| 2025-06-30 | $62.00 | $99.15M | $21.63M | $-104.30K | $-88.78M | $26.72M | (m) | 3 month · $1.39M 6 month · $2.52M | (m) | (m) |
| 2025-03-31 | $62.00 | $99.13M | $20.08M | $-104.30K | $-78.29M | $38.50M | (m) | 3 month · $1.13M | (m) | (m) |
| 2024-12-31 | $62.00 | $99.13M | $16.51M | $-104.30K | $-76.44M | $39.09M | 12 month · $89.63K | 12 month · $831.74K | 12 month · $979.80K | (m) |
| 2024-09-30 | $62.00 | $49.15M | $18.66M | $-104.30K | $-70.63M | $-2.57M | 9 month · $89.63K | 3 month · $193.74K 9 month · $917.15K | 3 month · $193.74K 9 month · $917.15K | 9 month · $3.94M |
| 2024-06-30 | $62.00 | $49.01M | $18.47M | $-104.30K | $-68.77M | $1.04M | 6 month · $89.63K | 3 month · $375.33K 6 month · $723.41K | (m) | 6 month · $3.94M |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | $535.15K | (m) | 3 month · $348.08K | (m) | (m) |
| 2023-12-31 | $62.00 | $39.76M | $17.29M | $-104.30K | $-61.65M | $-4.70M | 12 month · $1.34M | (m) | 12 month · $2.37M | (m) |
| 2023-12-22 | (m) | (m) | (m) | (m) | (m) | (m) | $80.04K | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | $-6.19M | (m) | (m) | 3 month · $697.07K 9 month · $1.90M | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | $-579.43K | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | $1.27M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $-1.32M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |